» Articles » PMID: 36926022

Cellular Senescence of Renal Tubular Epithelial Cells in Renal Fibrosis

Overview
Specialty Endocrinology
Date 2023 Mar 17
PMID 36926022
Authors
Affiliations
Soon will be listed here.
Abstract

Renal fibrosis (RF) is the common pathological manifestation of virtually all chronic kidney diseases (CKD) and one of the major causes of end-stage renal disease (ESRD), but the pathogenesis of which is still unclear. Renal tubulointerstitial lesions have been identified as a key pathological hallmark of RF pathology. Renal tubular epithelial cells are the resident cells of the tubulointerstitium and play an important role in kidney recovery versus renal fibrosis following injury. Studies in recent years have shown that senescence of renal tubular epithelial cells can accelerate the progression of renal fibrosis. Oxidative stress(OS), telomere attrition and DNA damage are the major causes of renal tubular epithelial cell senescence. Current interventions and therapeutic strategies for cellular senescence include calorie restriction and routine exercise, Klotho, senolytics, senostatics, and other related drugs. This paper provides an overview of the mechanisms and the key signaling pathways including Wnt/β-catenin/RAS, Nrf2/ARE and STAT-3/NF-κB pathway involved in renal tubular epithelial cell senescence in RF and therapies targeting renal tubular epithelial cell senescence future therapeutic potential for RF patients. These findings may offer promise for the further treatment of RF and CKD.

Citing Articles

Update of cellular senescence in kidney fibrosis: from mechanism to potential interventions.

Yang L, Ma L, Fu P, Nie J Front Med. 2025; .

PMID: 40011387 DOI: 10.1007/s11684-024-1117-z.


Renoprotective mechanisms of celastrol in high glucose-mediated HK-2 cell injury through inhibition of the PI3K/Akt/NF-κB signalling pathway.

Wang X, Abu Bakar M, Kassim M, Shariff K, Mohamad Rosdi M Biochem Biophys Rep. 2025; 41:101928.

PMID: 39926209 PMC: 11803244. DOI: 10.1016/j.bbrep.2025.101928.


Baicalin: a potential therapeutic agent for acute kidney injury and renal fibrosis.

Li X, Xu R, Zhang D, Cai J, Zhou H, Song T Front Pharmacol. 2025; 16:1511083.

PMID: 39911847 PMC: 11795133. DOI: 10.3389/fphar.2025.1511083.


Association between COPD and CKD: a systematic review and meta-analysis.

Liu Z, Ma Z, Ding C Front Public Health. 2024; 12:1494291.

PMID: 39737452 PMC: 11683117. DOI: 10.3389/fpubh.2024.1494291.


MSCs-derived HGF alleviates senescence by inhibiting unopposed mitochondrial fusion-based elongation in post-acute kidney injury.

Zhuang K, Wang W, Zheng X, Guo X, Xu C, Ren X Stem Cell Res Ther. 2024; 15(1):438.

PMID: 39563422 PMC: 11575204. DOI: 10.1186/s13287-024-04041-3.


References
1.
Yang C, Chen Z, Yu H, Liu X . Inhibition of Disruptor of Telomeric Silencing 1-Like Alleviated Renal Ischemia and Reperfusion Injury-Induced Fibrosis by Blocking PI3K/AKT-Mediated Oxidative Stress. Drug Des Devel Ther. 2020; 13:4375-4387. PMC: 6939406. DOI: 10.2147/DDDT.S224909. View

2.
Zhang T, Chi Y, Kang Y, Lu H, Niu H, Liu W . Resveratrol ameliorates podocyte damage in diabetic mice via SIRT1/PGC-1α mediated attenuation of mitochondrial oxidative stress. J Cell Physiol. 2018; 234(4):5033-5043. DOI: 10.1002/jcp.27306. View

3.
Pu W, Bai R, Zhou K, Peng Y, Zhang M, Hottiger M . Baicalein attenuates pancreatic inflammatory injury through regulating MAPK, STAT 3 and NF-κB activation. Int Immunopharmacol. 2019; 72:204-210. DOI: 10.1016/j.intimp.2019.04.018. View

4.
Bai M, Chen H, Ding D, Song R, Lin J, Zhang Y . MicroRNA-214 promotes chronic kidney disease by disrupting mitochondrial oxidative phosphorylation. Kidney Int. 2019; 95(6):1389-1404. DOI: 10.1016/j.kint.2018.12.028. View

5.
He W, Dai C, Li Y, Zeng G, Monga S, Liu Y . Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol. 2009; 20(4):765-76. PMC: 2663839. DOI: 10.1681/ASN.2008060566. View